Showing results (51-60 of 111) with videos related to
Sort By:
Pageof 12
Cell Stem Cell|January 9, 2026
Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapyZahir Shah, Lei Tian, Michael A Caligiuri, et al.ACS Chemical Biology|October 30, 2012
Ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017): a novel scaffold that resensitizes multidrug resistant leukemia cells to chemotherapySonia G Das, David L Hermanson, Nicholas Bleeker, et al.Seminars in Immunopathology|October 27, 2018
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cellsMichelle L Saetersmoen, Quirin Hammer, Bahram Valamehr, et al.Current Treatment Options in Neurology|October 19, 2019
Outcomes and Cost-Effectiveness of Autologous Hematopoietic Cell Transplant for Multiple SclerosisAnastasie M Dunn-Pirio, Benjamin M Heyman, Dan S Kaufman, et al.Stem Cells (Dayton, Ohio)|December 14, 2017
Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer ImmunotherapyHuang Zhu, Yi-Shin Lai, Ye Li, et al.Journal of Medicinal Chemistry|September 12, 2009
Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analoguesSonia G Das, Jignesh M Doshi, Defeng Tian, et al.Stem Cells (Dayton, Ohio)|February 4, 2006
Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunityXinghui Tian, Petter S Woll, Julie K Morris, et al.Trends in Biotechnology|March 1, 2023
Induced pluripotent stem cell-derived engineered T cells, natural killer cells, macrophages, and dendritic cells in immunotherapyDixuan Xue, Shan Lu, Hailing Zhang, et al.Blood|July 16, 2008
Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cellsColin H Martin, Petter S Woll, Zhenya Ni, et al.Plos One|March 28, 2015
Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cellsYawu Jing, Zhenya Ni, Jianming Wu, et al.Pageof 12